Articles Tagged With: vaccine
-
Vaccine Second Shot, Boosters Kick in Protective Effect
A study of healthcare and other frontline workers with COVID-19 showed that a history of two or three messenger ribonucleic acid vaccine doses lessened the severity of illness significantly.
-
Vaccination Against Mpox: Does it Work? Is it Safe?
Vaccination, either subcutaneously or intradermally, with the non-replicating JYNNEOS vaccine is safe and effective.
-
WHO Lobbies for Updated Tuberculosis Vaccines
International organization says these investments could drive economic growth, improve health equity and antimicrobial stewardship, and lower mortality rates.
-
Increasing Incidence of Stage IV Cervical Cancer
The incidence of stage IV cervical cancer in the United States between 2001 and 2018 increased. Rates were highest among Black women, but the annual rate of increase was highest among white women in the South age 40-44 years.
-
Reassuring Monkeypox Findings from Colorado
Although vigilance with infection control is critical, Colorado public health investigators concluded the risk of healthcare workers acquiring occupational monkeypox is “very low.” They meticulously identified and followed more than 300 medical staff that cared for patients who were later diagnosed with monkeypox.
-
Can Maternal COVID-19 Vaccination Protect Newborns?
In this case control study, 537 case infants younger than 6 months of age who were admitted to the hospital with COVID-19 were compared to 512 control infants who were hospitalized for other reasons; 16% of the case infants and 29% of the control infants had been born to mothers who had been fully vaccinated against COVID-19 during the pregnancy. The effectiveness of maternal vaccination against infant hospitalization for COVID-19 was 52% overall, 80% during the Delta variant period, and 38% during the Omicron variant period. Effectiveness increased when the vaccine was received after 20 weeks of pregnancy.
-
Endemic Monkeypox? Overall Decline, but Persistence Likely
Although the most likely scenario is that monkeypox cases will fall significantly in the next few months, transmission in the United States is “unlikely to be eliminated in the near future,” the Centers for Disease Control and Prevention reports.
-
Bivalent COVID-19 Vaccine (Booster Dose)
The FDA has amended the emergency use authorizations of two leading COVID-19 vaccines. Now, these new bivalent formulations can be used as a single booster dose (after primary or booster vaccination).
-
Mortality Projections Spur CDC Booster Approval
Clinicians and public health epidemiologists are loath to make bold moves with a dearth of data, but one dire projection recently swayed clearly uncomfortable members of the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices.
-
Smallpox and Monkeypox Vaccine, Live, Non-Replicating (Jynneos)
Jynneos can be administered to prevent smallpox and monkeypox in adults age 18 years and older who are at high risk for contracting the infections.